论文部分内容阅读
目的:研究并探讨早发型重度子痫前期患者期待治疗的妊娠结局,并分析其应用价值。方法:将我院从2013年10月22日至2014年11月22日期间选取的99例早发型重度子痫前期患者进行研究,99例患者妊娠时间都在34周以下,将99例早发型重度子痫前期患者分为三组,A组患者33例,孕周在28周以下,B组患者33例,孕周在28周至31周之间,C组患者33例,孕周在31周以上,统计记录患者的治疗情况,并对三组患者的并发症进行比较,对新生儿的结局进行比较。结果:A组患者、B组患者、C组患者的并发症差异较小(P>0.05),新生儿结局差异较大(P<0.05)。结论:对早发型重度子痫前期患者终止妊娠前实施期待治疗法安全可靠,降低了新生儿的死亡率。
OBJECTIVE: To study and explore the outcome of expectant treatment in patients with early-onset severe preeclampsia and to analyze its application value. Methods: Ninety-nine patients with early-onset severe preeclampsia selected from our hospital from October 22, 2013 to November 22, 2014 were enrolled. The pregnancy time of 99 patients was less than 34 weeks. 99 cases of early-onset Severe preeclampsia patients were divided into three groups, 33 patients in group A, gestational age less than 28 weeks, 33 patients in group B, gestational age between 28 weeks to 31 weeks, 33 patients in group C, gestational age at 31 weeks Above, the statistics of the treatment of patients, and complications of the three groups of patients were compared to compare the outcome of newborns. Results: There was no significant difference in complications between group A, group B and group C (P> 0.05), and neonatal outcome was significantly different (P <0.05). Conclusion: It is safe and reliable to pre-treat pregnant women with early-onset severe preeclampsia and reduce the neonatal mortality rate.